Core Insights - Rayonier Advanced Materials reported $417 million in revenue for Q4 2025, a year-over-year decline of 1.2% and an EPS of -$0.28 compared to -$0.10 a year ago, indicating a significant drop in profitability [1] - The revenue exceeded the Zacks Consensus Estimate of $365.5 million by 14.09%, while the EPS fell short of the consensus estimate of -$0.09 by 211.11% [1] Revenue Performance - High-Yield Pulp revenue was $28 million, surpassing the estimated $21 million [4] - Paperboard revenue reached $44 million, slightly above the estimated $42.5 million [4] - Cellulose Commodities generated $94 million, exceeding the $72.2 million estimate [4] - Cellulose Specialties revenue was $249 million, higher than the estimated $228.75 million [4] - Biomaterials revenue was $10 million, above the estimated $8.05 million [4] - Eliminations resulted in a loss of $-8 million, compared to the estimated $-7 million [4] EBITDA Analysis - EBITDA from continuing operations for Cellulose Specialties was $70 million, slightly above the $69.5 million estimate [4] - Cellulose Commodities reported an EBITDA of $-7 million, worse than the estimated $-6 million [4] - Corporate operations had an EBITDA of $-18 million, compared to the estimated $-14 million [4] - Paperboard operations generated an EBITDA of $4 million, exceeding the $3 million estimate [4] - High-Yield Pulp operations reported an EBITDA of $-5 million, in line with the estimate [4] - Biomaterials had an EBITDA of $-1 million, below the estimated $3 million [4] Stock Performance - Rayonier Advanced Materials shares returned +21% over the past month, contrasting with the Zacks S&P 500 composite's -1.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]